[1] Polimanti R, Piacentini S, Manfellotto D, et al. Human genetic variation of CYP450 superfamily:Analysis of functional diversity in worldwide populations[J]. Pharmacogenomics,2016,13(16):1951-1960.
[2] Perera V, Gross A S, Mclachlan A J. Measurement of CYP1A2 activity:A focus on caffeine as a probe[J].Current Drug Metabolism,2012,13(5):667-678.
[3] Ma Q, Lu A Y. CYP1A induction and human risk assessment:An evolving tale of in vitro and in vivo studies[J]. Drug Metabolism & Disposition,2007,35(7):1009-1016.
[4] 何兴瀚. 双峰驼CYP1A酶体外活性及其对探针药物代谢的影响[D]. 呼和浩特:内蒙古农业大学, 2015.
[5] An J H, Jeong L H, Hwa J B. Quantitative analysis of acetaminophen and its six metabolites in rat plasma using liquid chromatography/tandem mass spectrometry[J]. Biomedical Chromatography,2012,26(12):1596-1604.
[6] 陈氏红,严明,王柳萍,等. RP-HPLC法测定大鼠体内对乙酰氨基酚的血药浓度[J]. 西北药学杂志, 2010, 25(2):83-85.
[7] Wienkers L C, Heath T G. Predicting in vivo drug interactions from in vitro drug discovery data[J]. Nature Reviews Drug Discovery, 2005, 4(10):825-833.
[8] Iyer K R, Sinz M W. Characterization of Phase Ⅰ and Phase Ⅱ hepatic drug metabolism activities in a panel of human liver preparations[J].Chemico-Biological Interactions,1999,118(2):151-169.
[9] Peng W X, Li H D, Zhou H H. Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers[J]. European Journal of Clinical Pharmacology,2003, 59(3):237-241.
[10] Bachmann K, Sanyal G, Potter J, et al. In vivo evidence that theophyllineis metabolized principally by CYP1A in rats[J]. Pharmacology,1993, 47(1):1.
[11] Rees C B, Wu H, Li W. Cloning of CYP1A in Atlantic salmon (Salmo salar)[J]. Aquaculture,2005,246(1-4):11-23.
[12] 戴静. 氟喹诺酮类对猪和鸡肝微粒体CYP1A2活性影响研究[D].武汉:华中农业大学, 2009.
[13] 何兴瀚, 张文彬, 哈斯苏荣. 采用特异性探针药物法对双峰驼CYP1A酶体外活性的测定[J]. 中国兽医科学, 2015,11:1177-1183.
[14] 王艳, 高飞, 哈斯苏荣. 双峰驼CYP2D6酶体外孵育体系的建立与优化[J]. 动物医学进展, 2016, 37(4):58-62.
[15] 裴乐, 张文彬, 哈斯苏荣. 采用特异性探针药物法测定双峰驼CYP3A酶活性[J]. 中国农业科学, 2015, 48(16):3266-3274.
[16] Ma Q, Lu A Y. CYP1A induction and human risk assessment:An evolving tale of in vitro and in vivo studies[J]. Drug Metabolism & Disposition,2007, 35(7):1009-1016.
[17] 邓鸣, 张素芬, 牛坤,等. HPLC法测定人血浆中对乙酰氨基酚浓度[J]. 中国药事, 2008, 22(5):402-404.
[18] 关皎, 王丹, 郝乘仪,等. 对乙酰氨基酚家兔体内药动学研究[J]. 吉林医药学院学报,2011, 32(5):276-278.
[19] Sang K L, Bista S R, Jeong H, et al. The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats[J]. Archives of Pharmacal Research,2007,30(12):1629-1634.
[20] Acheampong A, Gyasi W O, Darko G, et al. Validated RP-HPLC method for simultaneous determination and quantification of chlorpheniramine maleate, paracetamol and caffeine in tablet formulation[J]. Springerplus,2016, 5(1):1-8.
[21] Neirinckx E, Vervaet C, De B S, et al. Species comparison of oral bioavailability, first-pass metabolismand pharmacokinetics of acetaminophen[J]. Research in Veterinary Science,2010,89(1):113-119.
[22] Vertzoni M V, Archontaki H A, Galanopoulou P. Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of acetaminophen and its major metabolites in rabbit plasma and urine after a toxic dose[J]. Journal of Pharmaceutical & Biomedical Analysis,2003,32(3):487-493.
[23] Abu-Qare A W, Abou-Donia M B. A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine[J]. Journal of Pharmaceutical & Biomedical Analysis,2001,26(5-6):939-947.
[24] Abdelaleem E A, Abdelwahab N S. Validated stability indicating RP-HPLC method for determination of paracetamol, methocarbamol and their related substances[J]. Analytical Methods,2012,5(2):541-545. |